Your browser doesn't support javascript.
Assessing the safety of home oximetry for COVID-19: a multisite retrospective observational study.
Clarke, Jonathan; Flott, Kelsey; Fernandez Crespo, Roberto; Ashrafian, Hutan; Fontana, Gianluca; Benger, Jonathan; Darzi, Ara; Elkin, Sarah.
  • Clarke J; Centre for Mathematics of Precision Healthcare, Imperial College London, London, UK j.clarke@imperial.ac.uk.
  • Flott K; Institute of Global Health Innovation, Imperial College London, London, UK.
  • Fernandez Crespo R; Institute of Global Health Innovation, Imperial College London, London, UK.
  • Ashrafian H; Institute of Global Health Innovation, Imperial College London, London, UK.
  • Fontana G; Institute of Global Health Innovation, Imperial College London, London, UK.
  • Benger J; NHS Digital, Leeds, UK.
  • Darzi A; Institute of Global Health Innovation, Imperial College London, London, UK.
  • Elkin S; National Heart and Lung Institute, Imperial College London, London, UK.
BMJ Open ; 11(9): e049235, 2021 09 14.
Article in English | MEDLINE | ID: covidwho-1408517
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

OBJECTIVES:

To determine the safety and effectiveness of home oximetry monitoring pathways for patients with COVID-19 in the English National Health Service.

DESIGN:

Retrospective, multisite, observational study of home oximetry monitoring for patients with suspected or proven COVID-19.

SETTING:

This study analysed patient data from four COVID-19 home oximetry pilot sites in England across primary and secondary care settings.

PARTICIPANTS:

A total of 1338 participants were enrolled in a home oximetry programme across four pilot sites. Participants were excluded if primary care data and oxygen saturations at rest at enrolment were not available. Data from 908 participants were included in the analysis.

INTERVENTIONS:

Home oximetry monitoring was provided to participants with a known or suspected diagnosis of COVID-19. Participants were enrolled following attendance to emergency departments, hospital admission or referral through primary care services.

RESULTS:

Of 908 patients enrolled into four different COVID-19 home oximetry programmes in England, 771 (84.9%) had oxygen saturations at rest of 95% or more, and 320 (35.2%) were under 65 years of age and without comorbidities. 52 (5.7%) presented to hospital and 28 (3.1%) died following enrolment, of which 14 (50%) had COVID-19 as a named cause of death. All-cause mortality was significantly higher in patients enrolled after admission to hospital (OR 8.70 (2.53-29.89)), compared with those enrolled in primary care. Patients enrolled after hospital discharge (OR 0.31 (0.15-0.68)) or emergency department presentation (OR 0.42 (0.20-0.89)) were significantly less likely to present to hospital than those enrolled in primary care.

CONCLUSIONS:

This study finds that home oximetry monitoring can be a safe pathway for patients with COVID-19; and indicates increases in risk to vulnerable groups and patients with oxygen saturations <95% at enrolment, and in those enrolled on discharge from hospital. Findings from this evaluation have contributed to the national implementation of home oximetry across England.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-049235

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-049235